Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe, Refractory Asthma”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Study completedNCT02560610
What this trial is testing

Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma

Who this might be right for
Severe Eosinophilic Asthma
Chiesi Farmaceutici S.p.A. 40
Large-scale testing (Phase 3)Study completedNCT01691859
What this trial is testing

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Who this might be right for
Asthma
GlaxoSmithKline 347
Testing effectiveness (Phase 2)Study completedNCT01000506
What this trial is testing

Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

Who this might be right for
Asthma
GlaxoSmithKline 621
Not applicableUnknownNCT04553276
What this trial is testing

Co-morbidity and Refractory Asthma - UK Severe Asthma Registry

Who this might be right for
Asthma
Queen's University, Belfast 4,800
Testing effectiveness (Phase 2)Study completedNCT00169962
What this trial is testing

Study of Pulmozyme to Treat Severe Asthma Episodes

Who this might be right for
Asthma
Northwell Health 51
Large-scale testing (Phase 3)Study completedNCT01842607
What this trial is testing

Determine Long-term Safety of Mepolizumab in Asthmatic Subjects

Who this might be right for
Asthma
GlaxoSmithKline 651
Not applicableActive Not RecruitingNCT05729711
What this trial is testing

TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

Who this might be right for
Bronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy)
AstraZeneca 416
Not applicableStudy completedNCT02566668
What this trial is testing

Immune Interactions in Severe Asthma

Who this might be right for
Asthma
University of Pittsburgh 115
Testing effectiveness (Phase 2)Study completedNCT00994175
What this trial is testing

A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma

Who this might be right for
Severe, Refractory AsthmaAirway InflammationAirflow Obstruction
National Heart, Lung, and Blood Institute (NHLBI) 15
Not applicableEnded earlyNCT00721097
What this trial is testing

Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics

Who this might be right for
AsthmaChronic Inflammatory Diseases
Nantes University Hospital 40
Not applicableStudy completedNCT00401986
What this trial is testing

RISA Extension Study - Long Term Safety

Who this might be right for
Asthma
Boston Scientific Corporation 14
Not applicableStudy completedNCT01185275
What this trial is testing

A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study)

Who this might be right for
Asthma
Washington University School of Medicine 133
Not applicableStudy completedNCT05063981
What this trial is testing

Treatment With Mepolizumab on Patients With Severe Refractory Eosinophilic Asthma

Who this might be right for
Severe Eosinophilic Asthma
Istituti Clinici Scientifici Maugeri SpA 15
Not applicableStudy completedNCT00276029
What this trial is testing

TNF Alpha in Refractory Asthma

Who this might be right for
Asthma
University Hospitals, Leicester 10
Not applicableEnded earlyNCT02872298
What this trial is testing

Evaluating the Safety and Feasibility of TLD for the Treatment of Severe Asthma

Who this might be right for
Asthma
Nuvaira, Inc. 2
Large-scale testing (Phase 3)Study completedNCT01691508
What this trial is testing

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Who this might be right for
Asthma
GlaxoSmithKline 135
Not applicableWithdrawnNCT02347462
What this trial is testing

Bilevel Positive Airway Pressure (BiPAP) for the Treatment of Moderate to Severe Acute Asthma Exacerbations

Who this might be right for
AsthmaStatus Asthmaticus
University of British Columbia
Not applicableStudy completedNCT03324230
What this trial is testing

Exploring Asthma Exacerbations in Mepolizumab Treated Patients

Who this might be right for
Asthma Brittle
Queen's University, Belfast 146
Testing effectiveness (Phase 2)Study completedNCT01097694
What this trial is testing

Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)

Who this might be right for
Asthma
Brigham and Women's Hospital 176
Large-scale testing (Phase 3)Study completedNCT01691521
What this trial is testing

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Who this might be right for
Asthma
GlaxoSmithKline 580
Next Page